Evaluation of presence of clone ST131 and biofilm formation in ESBL producing and non-producing Escherichia coli strains

被引:11
作者
Celebi, Demet [1 ,2 ]
Aydin, Elif [3 ]
Rakici, Erva [4 ]
Baser, Sumeyye [5 ]
Celebi, Ozgur [5 ]
Taghizadehghalehjoughi, Ali [6 ]
机构
[1] Ataturk Univ, Fac Vet Med, Dept Microbiol, TR-25240 Erzurum, Turkiye
[2] Ataturk Univ, Vaccine Applicat & Dev Ctr, TR-25240 Erzurum, Turkiye
[3] Kutahya Hlth Sci Univ, Tavsanli Vocat Sch Hlth Serv, TR-430200 Kutahya, Turkiye
[4] Recep Tayyip Erdogan Univ, Fac Med, Dept Med Microbiol, TR-53020 Rize, Turkiye
[5] Ataturk Univ, Fac Med, Dept Med Microbiol, TR-25240 Erzurum, Turkiye
[6] Seyh Edebali Univ, Fac Med, Dept Med Pharmacol, TR-11000 Bilecik, Turkiye
关键词
Biofilm; Multi-drug resistance; E; coli ST131; ESBL; High-risk clone; SPECTRUM BETA-LACTAMASES; CTX-M; ANTIBIOTIC-RESISTANCE; EMERGENCE; URINE; MULTIRESISTANT; TURKEY;
D O I
10.1007/s11033-023-08532-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ObjectiveEscherichia coli ST131 is a pandemic clone associated with multidrug resistance, starting with beta-lactamase production and fluoroquinolone resistance in the first place, leading to significant systemic infections. Clones that develop due to the frequency of antimicrobial resistance and the rate of spread in our country are important issues that need to be investigated. This study aims to investigate the incidence of ST131which is a "high-risk pandemic clone E. coli" in ESBL-producing and non-ESBL-producing strains, as well as their biofilm-forming abilities and antibiotic resistance rates.Materials and methodsA total of 86 E. coli isolates were used in the study. Bacterial identifications were performed by conventional and automated methods. The double disc synergy method was used to demonstrate the presence of ESBL. Molecular studies in all E. coli strains were performed by real-time PCR method.Findings: 86 strains were studied, of which 83.72% were urine, 6.98% were wound, 4.65% were blood, and 2.33% were tracheal aspirate and sputum. 79.07% of these strains were ESBL-positive. 58.1% of the strains were female, whereas 41.9% were male patients, and the average age was 46.2. Out of 86 strains, 38.72% were ST131 positive, the H30 subclone was detected in 27.27% of them, and the H30-Rx subclone was detected in all of the H30 subclone positive strains. The presence of the ESBL resistance gene was detected at the rate of TEM 41.86%, SHV 37.21%, CTX-M 36.04%, and OXA 4.65%. Most commonly SHV gene (54.54%) was seen in ST131 clone-positive samples. Finally, while it was found that 48.83% of the strains formed biofilm by any method, biofilm formation was detected in 69.7% of the samples that were positive for the ST131 clone.ResultOur study can reveal the dramatic prevalence of the ESBL-producing E. coli strains along with the high-risk ST131 clone, the dominance of the H30Rx subclone of this risky clone, as well as the importance of the influence of resistance mechanisms along with resistance and biofilm.
引用
收藏
页码:5949 / 5956
页数:8
相关论文
共 40 条
[1]   A First Insight into Escherichia coli ST131 High-Risk Clone Among Extended-Spectrum Beta-Lactamase-Producing Urine Isolates in Istanbul with the Use of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry and Real-Time PCR [J].
Aktas, Elif ;
Otlu, Baris ;
Erdemir, Duygu ;
Ekici, Hatice ;
Bulut, Emin .
MICROBIAL DRUG RESISTANCE, 2017, 23 (08) :1032-1036
[2]  
[Anonymous], 2015, BREAKPOINT TABLES IN
[3]  
Ausubel FM., 1995, Short protocols in molecular biology, V2, P2355
[4]  
Aykan SB, 2013, MIKROBIYOL BUL, V47, P603
[5]   Risk factors for extended-spectrum β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections [J].
Azap, Oe K. ;
Arslan, H. ;
Serefhanoglu, K. ;
Colakoglu, S. ;
Erdogan, H. ;
Timurkaynak, F. ;
Senger, S. S. .
CLINICAL MICROBIOLOGY AND INFECTION, 2010, 16 (02) :147-151
[6]   A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131 [J].
Banerjee, Ritu ;
Johnson, James R. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) :4997-5004
[7]  
Bayraktar B, 2010, MIKROBIYOL BUL, V44, P187
[8]   Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains [J].
Blanc, Veronique ;
Leflon-Guibout, Veronique ;
Blanco, Jorge ;
Haenni, Marisa ;
Madec, Jean-Yves ;
Rafignon, Gwenaele ;
Bruno, Pascale ;
Mora, Azucena ;
Lopez, Cecilia ;
Dahbi, Ghizlane ;
Dunais, Brigitte ;
Anastay, Magali ;
Branger, Catherine ;
Moreau, Richard ;
Pradier, Christian ;
Nicolas-Chanoine, Marie-Helene .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) :1231-1237
[9]   The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli [J].
Can, Fusun ;
Kurt-Azap, Ozlem ;
Ispir, Pelin ;
Nurtop, Elif ;
Seref, Ceren ;
Loclar, Ilayda ;
Aktas, Ozge Nur ;
Orhan, Yelda Ceren ;
Ergonul, Onder .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2016, 4 :49-52
[10]   Emerging Escherichia coli O25b/ST131 Clone Predicts Treatment Failure in Urinary Tract Infections [J].
Can, Fusun ;
Azap, Ozlem Kurt ;
Seref, Ceren ;
Ispir, Pelin ;
Arslan, Hande ;
Ergonul, Onder .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (04) :523-527